GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Obalon Therapeutics Inc (NAS:OBLN) » Definitions » Market Cap

Obalon Therapeutics (Obalon Therapeutics) Market Cap : $30.57 Mil (As of May. 08, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Obalon Therapeutics Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Obalon Therapeutics's share price for the quarter that ended in Mar. 2021 was $8.46001. Obalon Therapeutics's Shares Outstanding (EOP) for the quarter that ended in Mar. 2021 was 10.02 Mil. Therefore, Obalon Therapeutics's market cap for the quarter that ended in Mar. 2021 was $84.78 Mil.

Obalon Therapeutics's quarterly market cap increased from Sep. 2020 ($21.22 Mil) to Dec. 2020 ($34.97 Mil) and increased from Dec. 2020 ($34.97 Mil) to Mar. 2021 ($84.78 Mil).

Obalon Therapeutics's annual market cap declined from Dec. 2018 ($146.02 Mil) to Dec. 2019 ($44.03 Mil) and declined from Dec. 2019 ($44.03 Mil) to Dec. 2020 ($34.97 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Obalon Therapeutics's Enterprise Value for Today is $30.57 Mil.


Obalon Therapeutics Market Cap Historical Data

The historical data trend for Obalon Therapeutics's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Obalon Therapeutics Market Cap Chart

Obalon Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Market Cap
Get a 7-Day Free Trial 445.33 347.04 146.02 44.03 34.97

Obalon Therapeutics Quarterly Data
Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.70 16.37 21.22 34.97 84.78

Competitive Comparison of Obalon Therapeutics's Market Cap

For the Medical Devices subindustry, Obalon Therapeutics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Obalon Therapeutics's Market Cap Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Obalon Therapeutics's Market Cap distribution charts can be found below:

* The bar in red indicates where Obalon Therapeutics's Market Cap falls into.



Obalon Therapeutics Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Obalon Therapeutics's Market Cap for the fiscal year that ended in Dec. 2020 is calculated as

Market Cap (A: Dec. 2020 )=Share Price (A: Dec. 2020 )*Shares Outstanding (EOP) (A: Dec. 2020 )
=$4.5*7.7707
=$34.97

Obalon Therapeutics's Market Cap for the quarter that ended in Mar. 2021 is calculated as

Market Cap (Q: Mar. 2021 )=Share Price (Q: Mar. 2021 )*Shares Outstanding (EOP) (Q: Mar. 2021 )
=$8.46001*10.0216
=$84.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Obalon Therapeutics  (NAS:OBLN) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Obalon Therapeutics Market Cap Related Terms

Thank you for viewing the detailed overview of Obalon Therapeutics's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Obalon Therapeutics (Obalon Therapeutics) Business Description

Traded in Other Exchanges
N/A
Address
5421 Avenida Encinas, Suite F, Carlsbad, CA, USA, 92008
Obalon Therapeutics Inc is a medical device company that focuses on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. Its product includes Obalon Balloon System. Geographically, it derives all of its revenue from the United States.
Executives
Raymond V Dittamore director P O BOX 2050, GLENWOOD SPRINGS CO 81602
William J. Plovanic director C/O OBALON THERAPEUTICS, INC., 5421 AVENIDA ENCINAS, SUITE F, CARLSBAD CA 92008
Sharon Stevenson director C/O OBALON THERAPEUTICS, INC., 5421 AVENIDA ECINAS, SUITE F, CARLSBAD CA 92008
Douglas Fisher director 587 PATROL RD, WOODSIDE CA 94062
Lesley H Howe director
Kim P. Kamdar director C/O DOMAIN ASSOCIATES, L.L.C., ONE PALMER SQUARE, SUITE 515, PRINCETON NJ 08542
Andrew P Rasdal director, officer: President, CEO & Exec Chairman C/O DEXCOM, INC., 5555 OBERLIN DRIVE, SAN DIEGO CA 92121
Nooshin Hussainy officer: Chief Financial Officer C/O OBALON THERAPEUTICS, INC., 5421 AVENIDA ENCINAS, SUITE F, CARLSBAD CA 92008
Mark Brister officer: Chief Technology Officer C/O DEXCOM, INC., 5555 OBERLIN DRIVE, SAN DIEGO CA 92121
Robert J Macdonald officer: Chief Retail Officer C/O OBALON THERAPEUTICS INC., 5421 AVENIDA ENCINAS, SUITE F, CARLSBAD CA 92008
Amy Vandenberg officer: Chief Clinical & Reg Officer C/O OBALON THERAPEUTICS, INC., 5421 AVENIDA ENCINAS, SUITE F, CARLSBAD CA 92008
Nicole Vitullo 10 percent owner 3030 SCIENCE PARK ROAD, SAN DIEGO CA 92121
Brian H Dovey 10 percent owner ONE PALMER SQUARE, PRINCETON NJ 08542
Arnold L Oronsky 10 percent owner C/O INTERWEST PARTNERS, 467 FIRST STREET SUITE 201, LOS ALTOS CA 94022
Gilbert H Kliman 10 percent owner C/O INTERWEST PARTNERS, 467 FIRST STREET SUITE 201, LOS ALTOS CA 94022

Obalon Therapeutics (Obalon Therapeutics) Headlines

From GuruFocus